https://www.selleckchem.com/pr....oducts/dorsomorphin-
ministered flavonoids; however, the increased extracellular beta-glucuronidase of many tumors may give tumors privileged access to glucuronidated flavonoids, and nanopartical technology can improve the bioavailability of these agents. Enzymatically modified isoquercitrin has particular promise as a delivery vehicle for quercetin. Hence, it may be worthwhile to explore the clinical potential of flavones/flavonols as CK2 inhibitors for cancer therapy. OBJECTIVES Results from a recent study showed that the risk of cardiovascular
Like
Comment
Share
